BOB体育

Skip to main content

Mohammed Ruzieh, MD

Cardiologist (Heart Specialist)

Photo of Mohammed Ruzieh

Research at a glance

Top areas of exploration

  • Postural Orthostatic Tachycardia Syndrome , 7 publications
  • Pulmonary Embolism , 6 publications
  • Cardiovascular Diseases , 5 publications
  • Biomarkers , 4 publications

Research activity

71 publications

359 citations

Why is this important?

Active clinical trials

Librexia AF

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.

Investigator
Mohammed Ruzieh
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

71 publications

2024

Comparative effectiveness research using claims data: meticulous methods don鈥檛 solve old problems

European Heart Journal

2024

Natural recovery of cardiac allograft diastolic function, a retrospective longitudinal report.

American heart journal plus : cardiology research and practice

鈥�

2024

Predictors of left atrial appendage thrombus in atrial fibrillation patients undergoing cardioversion

Journal of Interventional Cardiac Electrophysiology

2024

Re-Analyses of 8 Historical Trials in Cardiovascular Medicine Assessing Multimorbidity Burden and Its Association with Treatment Response.

The American journal of medicine

鈥�

2024

Safety and Effectiveness of High-Intensity Statins Versus Low/Moderate-Intensity Statins Plus Ezetimibe in Patients With Atherosclerotic Cardiovascular Disease for Reaching LDL-C Goals: A Systematic Review and Meta-Analysis.

Clinical cardiology

鈥�